Drs. Cooper and Korman are performing a longitudinal observational pilot study on the behavior of established (plasma/serum) and investigative (cellular) biomarkers that are known to be associated with an increased risk of CVD event.
The biomarkers will be measured during and after one year of a continuous intensive therapy algorithm using standard-of-care systemic agents designed to achieve a decrease (>75%) in psoriasis.
This article describes the prevalence of various superficial fungal infections focusing on onychomycosis (fungal nail infections). This disease is by far the most difficult to cure is compared to other superficial fungal infections.
With millions of dollars being spent annually on oral and topical prescriptions, laser treatments, over-the-counter products, and home remedies, it is obvious that people are still bothered by their fungal toenail infections and are determined to get rid of them. Unfortunately, this is easier said than done. To successfully cure toenail fungal infections requires long treatment duration that may extend to a full year. Even then, complete cure is often unattainable.
Dr. Baron’s research is focused on understanding the effects light on the skin and/or how to utilize light-based modalities to treat skin diseases. The pilot study and data will lead to further grant applications and additional funding.
The workshop was a collaboration meeting with UH/CWRU, University of Manchester & IMPACT (Identification and Management of Psoriasis Associated ComorbidiTy Group). The meeting hosted national and international experts focused on developing behavior and therapeutic interventions to improve psoriasis and cardiovascular health comorbidities.
Several individuals and work groups where recognized at this year’s department employee appreciation event for their hard work and process improvements implemented during 2014.
In September 2014 we welcomed back Dr. Jennifer Bahner on her return to the UH Dermatology family.